Superior and effective microbiome therapeutics

About us

CHAIN Biotechnology Ltd develops Clostridium-based microbial technology for high-value healthcare products. We produce novel 2nd generation live biotherapeutic products for chronic gut-related diseases.


Our Clostridium Assisted Drug Delivery (CADD™) platform is a targeted, robust and versatile method of delivering therapeutic bioactives to the gut in a safe, proven and affordable way.


CHAIN is developing several therapeutic compounds targeted to the gut microbiome in the large intestine that can be delivered by our CADD™ technology. Our lead product targets Inflammatory Bowel Disease.